EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis

Alessio Rizzo, Manuela Racca iD, Federico Garrou, Elisabetta Fenocchio iD, Luca Pellegrino, Domenico Albano iD, Francesco Dondi iD, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia iD

International Journal of Molecular Sciences · 14.06.2023 · 24 (12) · 10136

DOI: 10.3390/ijms241210136 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.06.2023. Verfasst von Alessio Rizzo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Stomach Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various papers have introduced the use of positron emission tomography (PET) with [68Ga]Ga-radiolabeled fibroblast-activation protein inhibitor (FAPi) radiopharmaceuticals in different subtypes of gastric cancer (GC). Our aim was to assess the diagnostic performance of this novel molecular imaging technique in GC with a systematic review and meta-analysis. A straightforward literature search of papers concerning the diagnostic performance of FAP-targeted PET imaging was performed. Original articles evaluating this novel molecular imaging examination in both newly diagnosed GC patients and GC patients with disease relapse were included. The systematic review included nine original studies, and eight of them were also eligible for meta-analysis. The quantitative synthesis provided pooled detection rates of 95% and 97% for the assessment of primary tumor and distant metastases, respectively, and a pooled sensitivity and specificity of 74% and 89%, respectively, for regional lymph node metastases. Significant statistical heterogeneity among the included studies was found only in the analysis of the primary tumor detection rate (I2 = 64%). Conclusions: Beyond the limitations of this systematic review and meta-analysis (i.e., all the included studies were conducted in Asia, and using [18F]FDG PET/CT as a comparator of the index test), the quantitative data provided demonstrate the promising diagnostic performance of FAP-targeted PET imaging in GC. Nevertheless, more prospective multicentric studies are needed to confirm the excellent performances of FAP-targeted PET in this cluster of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyStomach NeoplasmsHumansProspective StudiesNeoplasm Recurrence, LocalPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Gallium Radioisotopes

Stichwörter der Autor:innen

FAPiPETfibroblast-activating protein inhibitorgastric canceroncologypositron emission tomographystomach

Substanzen

RadiopharmaceuticalsFluorodeoxyglucose F18Gallium Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy.
  • Nuclear Medicine Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, 10126 Turin, Italy.
  • Department of Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy.
  • Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy.
  • Division of Nuclear Medicine, Università degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
  • Unità di Medicina Nucleare, GSTeP Radiopharmacy-TracerGLab, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.

ORCID-Profile: Manuela Racca, Elisabetta Fenocchio, Domenico Albano, Francesco Dondi, Giorgio Treglia

Zitieren

APA

Rizzo, A., Racca, M., Garrou, F., Fenocchio, E., Pellegrino, L., Albano, D., Dondi, F., Bertagna, F., Annunziata, S., & Treglia, G. (2023). Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(12), 10136. https://doi.org/10.3390/ijms241210136

Vancouver

Rizzo A, Racca M, Garrou F, Fenocchio E, Pellegrino L, Albano D, et al. Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023;24(12):10136. doi:10.3390/ijms241210136

BibTeX
@article{Rizzo2023,
  author = {Rizzo, Alessio and Racca, Manuela and Garrou, Federico and Fenocchio, Elisabetta and Pellegrino, Luca and Albano, Domenico and Dondi, Francesco and Bertagna, Francesco and Annunziata, Salvatore and Treglia, Giorgio},
  title = {Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {12},
  pages = {10136},
  doi = {10.3390/ijms241210136}
}
Kostenlos starten →